abstract |
The present invention generally includes IL-18, also known as interferon-γ-inducing factor (IGIF), for the prevention and / or treatment of viral diseases caused by HIV, HSV, HPV, HAV, HBV and HCV. It relates to the use of IL-18 in combination with compositions and other agents. |